Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
Niemann N, Jankovic J.
Drugs. 2018 Apr;78(5):525-541. doi: 10.1007/s40265-018-0874-x. Review. Erratum in: Drugs. 2018 Mar 10;:. Dosage error in article text.
Similar articles
Valbenazine: First Global Approval.
Kim ES.
Drugs. 2017 Jul;77(10):1123-1129. doi: 10.1007/s40265-017-0770-9. Review.
Valbenazine as the first and only approved treatment for adults with tardive dyskinesia.
Sarva H, Henchcliffe C.
Expert Rev Clin Pharmacol. 2018 Mar;11(3):209-217. doi: 10.1080/17512433.2018.1429264. Epub 2018 Jan 23. Review.
Valbenazine for the treatment of tardive dyskinesia.
Seeberger LC, Hauser RA.
Expert Opin Pharmacother. 2017 Aug;18(12):1279-1287. doi: 10.1080/14656566.2017.1353078. Epub 2017 Aug 2.
VMAT2 Inhibitors: New Drugs for the Treatment of Tardive Dyskinesia.
Kim AP, Baker DE, Levien TL.
Consult Pharm. 2018 Apr 1;33(4):201-209. doi: 10.4140/TCP.n.2018.201. Review.
Barquero N.
Drugs Today (Barc). 2016 Dec;52(12):665-672. doi: 10.1358/dot.2016.52.12.2570977. Review.
Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.
Solmi M, Pigato G, Kane JM, Correll CU.
Drug Des Devel Ther. 2018 May 14;12:1215-1238. doi: 10.2147/DDDT.S133205. eCollection 2018. Review.
Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia.
Meyer JM.
CNS Spectr. 2016 Dec;21(S1):13-24. doi: 10.1017/S1092852916000730. Review.
Valbenazine for Tardive Dyskinesia.
Freudenreich O, Remington G.
Clin Schizophr Relat Psychoses. Summer 2017;11(2):113-119. doi: 10.3371/CSRP.OFGR.071717. Review.
Dopamine depleters in the treatment of hyperkinetic movement disorders.
Jankovic J.
Expert Opin Pharmacother. 2016 Dec;17(18):2461-2470. Review.
Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
Davis MC, Miller BJ, Kalsi JK, Birkner T, Mathis MV.
N Engl J Med. 2017 Jun 29;376(26):2503-2506. doi: 10.1056/NEJMp1704898. Epub 2017 May 10. No abstract available.
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF.
Am J Psychiatry. 2017 May 1;174(5):476-484. doi: 10.1176/appi.ajp.2017.16091037. Epub 2017 Mar 21.
Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L.
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.13030. Epub 2017 Oct 12. Review.
Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
Müller T.
Expert Opin Investig Drugs. 2015 Jun;24(6):737-42. doi: 10.1517/13543784.2015.1029573. Epub 2015 Mar 25.
Deuterium Tetrabenazine for Tardive Dyskinesia.
Cummings MA, Proctor GJ, Stahl SM.
Clin Schizophr Relat Psychoses. 2018 Jan;11(4):214-220. doi: 10.3371/CSRP.CUPR.010318. Review.
Expert Rev Neurother. 2017 Dec;17(12):1135-1144. doi: 10.1080/14737175.2017.1386556. Epub 2017 Oct 12. Review.
Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
Paton DM.
Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164. Review.
Valbenazine (Ingrezza) for tardive dyskinesia.
[No authors listed]
Med Lett Drugs Ther. 2017 May 22;59(1521):83-84. No abstract available.
Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.
Med Lett Drugs Ther. 2018 Apr 23;60(1545):65-68. No abstract available.
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Int J Clin Pract. 2017 Jul;71(7). doi: 10.1111/ijcp.12964. Epub 2017 May 12. Review.
Filters: Manage Filters